Aspen Grove Capital, LLC

Position in GSK — GSK plc

CIK 1806027 AVON, CO

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,209,958

-$78,949 QoQ

Shares Held

23,082

-1.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#325

of 1,033 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aspen Grove Capital, LLC holds $11,919,703 across 10 Drug Manufacturers - General names. GSK ranks #3 (10.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,303	$5,161,147
2	PFE	Pfizer Inc	63,351	$1,525,492
3	GSK	GSK plc This page	23,082	$1,209,958
4	AMGN	Amgen Inc	2,888	$1,045,802
5	JNJ	Johnson & Johnson	3,238	$822,354
6	ABBV	AbbVie Inc.	2,252	$566,693
7	MRK	Merck & Co., Inc.	3,683	$473,265
8	AZN	Astrazeneca PLC	2,371	$449,589

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,209,958	23,082	-1.2%	Shares	Sole	2026-08-14
2026-03-31	$1,288,907	23,354	+7.2%	Shares	Sole	2026-05-14
2025-12-31	$1,068,238	21,783	-24.8%	Shares	Sole	2026-02-17
2025-09-30	$1,249,870	28,959	-17.0%	Shares	Sole	2025-11-14
2025-06-30	$1,339,507	34,883	+2.5%	Shares	Sole	2025-08-14
2025-03-31	$1,318,787	34,042	+10.6%	Shares	Sole	2025-05-14
2024-12-31	$1,041,114	30,784	-4.6%	Shares	Sole	2025-02-14
2024-09-30	$1,318,543	32,254	-0.0%	Shares	Sole	2024-11-13
2024-06-30	$1,242,048	32,261	+0.2%	Shares	Sole	2024-08-14
2024-03-31	$1,380,285	32,197	0.0%	Shares	Sole	2024-05-15
2023-12-31	$1,193,220	32,197	+0.5%	Shares	Sole	2024-02-14
2023-09-30	$1,160,833	32,023	+0.5%	Shares	Sole	2023-11-13
2023-06-30	$1,136,096	31,877	+2.3%	Shares	Sole	2023-08-14
2023-03-31	$1,109,099	31,172	+3.9%	Shares	Sole	2023-05-15
2022-12-31	$1,054,481	30,008	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.